MGC Diagnostics (MGCD) Reports Q2 EPS of $0.02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall St set to open higher after inflation data, earnings boost
- Oil prices rise after ship attacks, US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results
June 2, 2015 4:01 PM EDTSAINT PAUL, Minn., June 2, 2015 /PRNewswire/ --Â MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the second quarter ended April 30, 2015.
2015 second quarter domestic equipment, supplies and accessories revenues, compared to the 2014 second quarter, were flat at $4.2 million. During the quarter, competitive account conversions totaled 12 accounts, or $442,000 in revenue, compared to 12 accounts, or $850,000 in revenue for the same quarter last year, and MediSoft contributed domestic revenues of $96,000 from its U.S. distributor. Excluding the effect of revenues from competitive conversions and domestic MediSoft revenue,... More